Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency
Clinical trial NCT02808052 · TERMINATED
Trial details
- NCT number
- NCT02808052
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-29
- Primary completion
- 2018-06-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.